Synopsis: Security software provider’s shares rose over 8% today’s trading session after announcing Q2 results.
A small-cap company that is in the business of providing security software products is in the spotlight today after posting Q2FY26 results. Read the article below for detailed insights into its performance.
With a market capitalization of Rs. 1,904.75 crore, the shares of Quick Heal Technologies Limited were trading at Rs. 352.20, up by 3.12 percent from its previous day’s closing price of Rs. 341.40. In today’s trading session the stock has touched an intraday high of Rs. 371.40, implying 8.78 percent from its previous day’s closing price.
Q2FY26 Results
Quick Heal Technologies Limited reported Rs. 83.52 crore in revenue for the second quarter of FY26, a 13.65 percent increase over the Rs. 73.49 crore for the same period in FY25. It increased by 45.94 percent as compared to Rs. 57.23 crore in Q1 FY26.
The company’s EBITDA for Q2 FY26 stood at Rs. 9.23 crore, up by 200.65 percent from Rs. 3.07 crore in Q2 FY25, and it has turnaround from a loss of Rs. 9.73 crore in Q1 FY26. The company reported EBITDA margin of 11.1% in Q2 FY26, which increased from EBITDA margin of 4.2% in Q2 FY25.
The consolidated net profit for the second quarter of FY26 was Rs. 7.91 crore, which was 90.60 percent higher than the Rs. 4.15 crore reported in the Q2 FY25 and it has turnaround from a loss of Rs. 5.51 crore in Q1 FY26. The company reported PAT Margin of 9.5% in Q2 FY26, which increased as compared to 5.7% in Q2 FY25.
Profit growth was also reflected in earnings per share (EPS), which increased to approximately Rs. 1.43 in Q2 FY26 from Rs. 0.77 in Q2 FY25.
Other Updates
Quick Heal Technologies reported strong business momentum, marked by the first order received for its Seqrite Data Privacy solution, highlighting progress in its enterprise segment. The company recorded steady growth in its retail business and an expanding order book exceeding ₹27 crore, supported by continued positive traction in international markets.
Additionally, deferred revenue stood at ₹17.2 crore, reflecting a healthy pipeline of future income, while its government business segment showed signs of accelerating growth, reinforcing overall business momentum.
Also read: Microcap stock in focus after receiving ₹5 Cr order for power systems and automation panels
About the company
Quick Heal Technologies Limited, founded in 1995 and headquartered in Pune, India, is a leading provider of cybersecurity software and solutions catering to consumers, small businesses, government institutions, and enterprises both in India and abroad.
The company develops and markets a wide range of antivirus and security products under its flagship Quick Heal brand, including Total Security, Internet Security, Antivirus Pro, and specialized versions for Mac and Android. It also offers the Quick Heal AntiFraud.AI solution, which focuses on consumer fraud prevention and protection against online scams.
Under its Seqrite brand, Quick Heal delivers advanced enterprise-grade security offerings such as Endpoint Protection, Endpoint Detection and Response (EDR), Extended Detection and Response (XDR), Mobile Device Management (MDM), Zero Trust Network Access (ZTNA), and data privacy tools.
Additionally, the company provides specialized enterprise services like managed detection and response and compliance solutions for the Digital Personal Data Protection (DPDP) Act. Through continuous innovation and a broad cybersecurity portfolio, Quick Heal addresses the growing digital threats faced by individuals and organizations worldwide.
Written By Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
